• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善肝细胞癌护理的患者宪章。

A Patient Charter to Improve Care for Hepatocellular Carcinoma.

作者信息

Hassan Yasmine, Kautz Achim, James Cary, Lee Dee, Langenbacher Diane, Bouffet Eric, Chakowa Jade, Hicks Jessica, Ward John W, Kuschnereit Lili Anna, Allaire Manon, Zhang Tingting, Huang Chi Zeena

机构信息

Department of Global Policy, Advocacy and Health Equity, AstraZeneca, Gaithersburg, MD, USA.

International Liver Cancer Movement, Cologne, Germany.

出版信息

J Hepatocell Carcinoma. 2025 Aug 20;12:1849-1859. doi: 10.2147/JHC.S526170. eCollection 2025.

DOI:10.2147/JHC.S526170
PMID:40861312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12375318/
Abstract

PURPOSE

To establish a patient charter that articulates the principles of quality care for individuals living with hepatocellular carcinoma (HCC), aiming to improve patient outcomes and survival rates globally.

METHODS

A multidisciplinary group comprising healthcare professionals, patient advocacy representatives, and policymakers convened to identify the critical areas of unmet need in HCC care. The group shared patient experiences, barriers, and insights - particularly with input from Patient Advocacy Groups (PAGs) - to better understand the challenges faced by patients. They reviewed existing literature, current care practices, and patient experiences to formulate a patient charter that outlines the principles of quality care for HCC.

RESULTS

The patient charter identifies the seven principles of quality care that people with HCC or at risk of developing HCC should expect to receive in order to benefit from improved outcomes and increased survival. These principles address the need for policy prioritization, early diagnosis, multidisciplinary care, personalized treatment, shared decision-making, stigma-free access to services and increased research funding.

CONCLUSION

The patient charter serves as a call to action for stakeholders to unite in enhancing the care and treatment of HCC, with the ultimate goal of improving health outcomes for patients.

摘要

目的

制定一份患者宪章,阐明针对肝细胞癌(HCC)患者的优质护理原则,旨在提高全球患者的治疗效果和生存率。

方法

一个由医疗保健专业人员、患者权益倡导代表和政策制定者组成的多学科小组召开会议,以确定HCC护理中未得到满足的关键需求领域。该小组分享了患者的经历、障碍和见解——特别是来自患者权益倡导团体(PAGs)的意见——以更好地了解患者所面临的挑战。他们回顾了现有文献、当前的护理实践和患者经历,以制定一份概述HCC优质护理原则的患者宪章。

结果

患者宪章确定了优质护理的七项原则,HCC患者或有患HCC风险的人应期望获得这些原则,以便从改善治疗效果和提高生存率中受益。这些原则涉及政策优先排序、早期诊断、多学科护理、个性化治疗、共同决策、无歧视地获得服务以及增加研究资金的需求。

结论

患者宪章呼吁利益相关者团结起来,加强对HCC的护理和治疗,最终目标是改善患者的健康状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e551/12375318/ac58384d1102/JHC-12-1849-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e551/12375318/cbfb6c7b6e4c/JHC-12-1849-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e551/12375318/ac58384d1102/JHC-12-1849-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e551/12375318/cbfb6c7b6e4c/JHC-12-1849-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e551/12375318/ac58384d1102/JHC-12-1849-g0002.jpg

相似文献

1
A Patient Charter to Improve Care for Hepatocellular Carcinoma.改善肝细胞癌护理的患者宪章。
J Hepatocell Carcinoma. 2025 Aug 20;12:1849-1859. doi: 10.2147/JHC.S526170. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Addressing Inequalities in Long Covid Healthcare: A Mixed-Methods Study on Building Inclusive Services.解决长期新冠医疗保健中的不平等问题:一项关于建立包容性服务的混合方法研究。
Health Expect. 2025 Aug;28(4):e70336. doi: 10.1111/hex.70336.
4
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
5
Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs).制定基于证据的指南,用于在患者信息单页/说明书(PrinciPILs)中描述潜在益处和危害,这些信息单页既能提供信息又不会造成伤害。
Health Technol Assess. 2025 Aug;29(43):1-20. doi: 10.3310/GJJH2402.
6
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊:ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
9
NIH consensus development conference draft statement on vaginal birth after cesarean: new insights.美国国立卫生研究院关于剖宫产术后阴道分娩的共识发展会议声明草案:新见解
NIH Consens State Sci Statements. 2010 Mar 10;27(3):1-42.
10
Optimizing the Journey for Patients With Nontuberculous Mycobacterial (NTM) Lung Disease in the United Kingdom.优化英国非结核分枝杆菌(NTM)肺病患者的就医流程。
J Patient Exp. 2025 Aug 12;12:23743735251367077. doi: 10.1177/23743735251367077. eCollection 2025.

本文引用的文献

1
Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights.癌症患者的生育力保存:美国临床肿瘤学会指南临床见解
JCO Oncol Pract. 2025 Apr 16:OP2500223. doi: 10.1200/OP-25-00223.
2
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.2024年亚太肝脏研究学会肝细胞癌全身治疗临床实践指南
Hepatol Int. 2024 Dec;18(6):1661-1683. doi: 10.1007/s12072-024-10732-z. Epub 2024 Nov 21.
3
Improving hepatocellular carcinoma surveillance in the United Kingdom: challenges and solutions.改善英国肝细胞癌监测:挑战与解决方案
Lancet Reg Health Eur. 2024 Jun 15;43:100963. doi: 10.1016/j.lanepe.2024.100963. eCollection 2024 Aug.
4
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.晚期肝细胞癌的系统治疗:ASCO 指南更新。
J Clin Oncol. 2024 May 20;42(15):1830-1850. doi: 10.1200/JCO.23.02745. Epub 2024 Mar 19.
5
Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape.2024年肝细胞癌的管理:不断演变的治疗格局中的多学科模式
Cancers (Basel). 2024 Feb 4;16(3):666. doi: 10.3390/cancers16030666.
6
Improving personalised care, through the development of a service evaluation tool to assess, understand and monitor delivery.通过开发服务评估工具来评估、理解和监测交付,从而改善个性化护理。
BMJ Open Qual. 2023 Sep;12(3). doi: 10.1136/bmjoq-2023-002324.
7
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.肝细胞癌中癌症疫苗及疫苗策略的综合综述
Vaccines (Basel). 2023 Aug 12;11(8):1357. doi: 10.3390/vaccines11081357.
8
Nutritional Support for Liver Diseases.肝脏病的营养支持。
Nutrients. 2023 Aug 19;15(16):3640. doi: 10.3390/nu15163640.
9
Addressing racial and ethnic disparities in US liver cancer care.解决美国肝癌护理中的种族和民族差异。
Hepatol Commun. 2023 Jun 22;7(7). doi: 10.1097/HC9.0000000000000190. eCollection 2023 Jul 1.
10
Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?男性和女性肝细胞癌患者的预后真的存在差异吗?
Cancers (Basel). 2023 May 24;15(11):2892. doi: 10.3390/cancers15112892.